Paolo Springhetti (@Springhetti_P) profile picture

MD, Cardiologist, Echocardiography - Postdoctoral Fellow at Québec Heart and Lung Institute (Laval University, QC)

Verona, Veneto
Joined July 2023
Photo by Paolo Springhetti (@Springhetti_P)Photo by Paolo Springhetti (@Springhetti_P)Photo by Paolo Springhetti (@Springhetti_P)Photo by Paolo Springhetti (@Springhetti_P)Photo by Paolo Springhetti (@Springhetti_P)Photo by Paolo Springhetti (@Springhetti_P)
#EHJCVI 💡 What are the sex differences in the evolution and outcomes of mild–moderate AS with pLVEF? 📌 Men: faster rise in peak velocity and mean gradient 📌 Women: more concentric LV remodelling, hypertrophy, and declining SV 📚 Dive into the data 👉 doi.org/10.1093/ehjci/jeaf18…
1
10
14
1,310
This comprehensive review examined the durability of TAVI compared to SAVR, addressing definitions, mechanisms, and long-term data on bioprosthetic valve dysfunction and failure. While midterm outcomes are comparable, long-term durability remains to be fully established. @TernacleJ @PPibarot ow.ly/uXZS50SBTC9 #Cardiology #MedicalResearch #TAVI #SAVR #HealthcareInnovation
20
45
3,898
Paolo Springhetti retweeted
The flow knows - Severe MR in paradoxical LFLGAS is associated with worse outcomes. AVR may improve survival—hemodynamic assessment by echo is key! @ShaniDahanMD @JudyHungMD @MghHeartHealth #AHAJournals ahajrnls.org/42e9qgm
9
28
2,267
Paolo Springhetti retweeted
3D echo improves TR severity grading vs. 2D, closely matching CMR. A new 5-class CMR grading scheme enhances multimodality assessment! @DoldiP #AHAJournals ahajrnls.org/4hQ2USN
1
16
28
2,606
Paolo Springhetti retweeted
And here are finally the 5-year results of Evolut Low Risk, a trial in which the self-expanding prosthesis holds its own against surgery. A trial where, let’s remember, the average age was 74 years. For years, to the question: 'How long does a TAVI prosthesis last?' we didn’t know what to answer. Now I think we can say with certainty: 'At least 5 years.' Still too early to claim victory, but not the disaster that some predicted years ago either. #ACC25 jacc.org/doi/10.1016/j.jacc.…
54
2
151
11,596
Incidence and Impact of Structural Valve Deterioration Following #TAVI: a Multicenter Real-World Study ➡️ In this real-world registry, the incidence of SVD at 8-years after TAVI was relatively low ➡️ academic.oup.com/ehjcimaging… @ESC_Journals @bernhard_gerber @DonalErwan @JGrapsa
8
19
1,741
The rise of CIED-related TR demands awareness, better screening, and refined interventional strategies. A must-read perspective by M. Andreas, Philipp E. Bartko, @AndreasZirlik et al. 📖 ow.ly/7UQb50VfCHs #CIED #TricuspidRegurgitation #StructuralHeart #TTVR #TTEER
28
1
65
6,456
Sex-related differences in prosthesis-patient mismatch after surgical aortic valve replacement and long-term outcomes. Read more in #EHJ 👉 ow.ly/3ylC50V3n3k @RoccoMontone @ehj_ed #SAVR
1
10
1
32
4,865
#PPhilippe (editor-in-chief) presents the #JHVS, fully dedicated to heart valve disease, and which aims to advance understanding and improve patient outcomes by publishing high-quality research across diverse disciplines, from basic science to patient advocacy. Read more here👇 journals.sagepub.com/doi/ful…
3
3
16
515
Paolo Springhetti retweeted
After 3 years of relentless hard work, passion, and dedication to #cvimaging and research in TR, our brilliant PhD student @michetomaselli has successfully defended his thesis! Michele, your fantastic journey has been inspiring for so many fellows and researchers that had the chance to work with you. The future is bright, and I’m honored to have been part of your path and to work with you daily. Congratulations—this is just the beginning! @lpbadano @ClementA25 @giorgio_oliver @Fraheilbron @Springhetti_P @fpperelli @GParati22 @TwittAuxologico @unimib #3DEcho #PhDSuccess #TricuspidRegurgitation #ProudMentor #FutureLeader
We celebrate @michetomaselli who succesfully defended his PhD thesis about the advanced assessment of patients with secondary TR. Fantastic redult of 3 years of hard work
4
8
1
51
3,750
Paolo Springhetti retweeted
Transapical #TMVR after ELASTA-Clip is a feasible and less invasive option for the management of failed M-TEER that can be performed with acceptable results in a carefully selected patient population. jacc.org/doi/10.1016/j.jcin.… #JACCINT #cvSurg #TEER @FabienPraz @DaryoushSamim
1
20
45
5,873
Paolo Springhetti retweeted
T-TEER improves 1-year survival in patients with intermediate-stage tricuspid regurgitation💡 No benefit seen in early or advanced stages 🚑 Timing of intervention is crucial for optimal outcomes! 🫀 jacc.org/doi/10.1016/j.jcin.… #TEER #Cardiology #vhdTR @PhilippLurz
2
49
2
126
15,831
Paolo Springhetti retweeted
Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography bit.ly/3VSS7zg
1
3
4
1,183
Paolo Springhetti retweeted
Yearly incidence of CE after #TAVR is low. In the event of CE, pts who have not undergone #PCI have a worse outcome. SEV pts have a higher rate of unfavorable outcomes & are less likely to undergo PCI, especially when admitted to non-TAVR centers jacc.org/doi/10.1016/j.jcin.… #JACCINT
1
7
3
34
5,604
Congratulations! Happy to be involved with our team in this nice project. Thank you all for the great collaboration to an important paper. @lpbadano @michetomaselli @denisamuraru @Springhetti_P
3
10
1,010
Check out our latest paper pubblished on the Canadian Journal of Cardiology🔥we identified outcome-based cutoffs for both corrected EROA and 3D-derived RV volumes, RVEF and RV-to-PA coupling!The framework among these parameters is complex! onlinecjc.ca/article/S0828-2…
2
11
2
20
2,554
Paolo Springhetti retweeted
In aortic stenosis, #yesCCT assessment of fibrocalcific AV volume correlates with disease severity and hemodynamic progression. bit.ly/49jVrJn #JACCIMG #cvVHD @ClavelLabo
13
32
6,540
Paolo Springhetti retweeted
Check out our latest paper on the prognostic impact of correcting the PISA method in STR. Moving towards a personalized approach in quantitating STR. onlinejase.com/article/S0894… #JASE @lpbadano @denisamuraru @Springhetti_P @noela_radu @ClementA25 @dianarflorescu
6
2
16
2,262
Paolo Springhetti retweeted
The PROTECTED TAVR trial showed that the use of cerebral embolic protection did not have a significant effect on the incidence of periprocedural stroke during transcatheter aortic valve replacement. #TCT2024 ja.ma/3YnWhiU
9
23
4,263
Paolo Springhetti retweeted
TAVR UNLOAD just presented at TCT. First RCT in moderate AS and HFrEF. The trial did not meet the primary endpoint at last FU but early TAVR was superior to clinical surveillance at 1 year.
3
16
3
58
10,672